Company: REVB
Filing Date: 2025-05-20
Form Type: S-1
Source: 0001213900-25-045828
Chunk: 12

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-05-20
Form: S-1
Chunk 12
---
 ownership on their holders, such as voting rights or the right to receive dividends, but rather merely represent the right to acquire shares of common stock at a fixed price. Specifically, commencing on the date of issuance, holders of the common warrants may acquire the shares of common stock issuable upon exercise of such warrants at an exercise price of $ ● per share of common stock, and holders of the pre-funded warrants may acquire the shares of common stock issuable upon exercise of such warrants at an exercise price of $0.0001 per share of common stock. Moreover, following this offering, the market value of the warrants and pre-funded warrants is uncertain and there can be no assurance that the market value of the warrants or pre-funded warrants will equal or exceed their respective public offering prices. There can be no assurance that the market price of the shares of common stock will ever equal or exceed the exercise price of the warrants or pre-funded warrants, and consequently, whether it will ever be profitable for holders of warrants to exercise the warrants or for holders of the pre-funded warrants to exercise the pre-funded warrants. If the Class H-1 Warrants are exercised by way of a one-time only “zero exercise price” option, stockholders may suffer substantial dilution. If the Class H-1 Warrants are exercised by way of a one-time only “zero exercise price” option, assuming receipt of Stockholder Approval, such exercising holder will receive 10 shares of common stock for each Class H-1 Warrant they exercise, without any cash payment to us. If a “zero exercise price” option is utilized, such exercise will result in substantial dilution to stockholders. As a result of this feature, we do not expect to receive any cash proceeds from the exercise of the Class H-1 Warrants in these circumstances because it is highly unlikely that a Class H-1 Warrant holder will elect to pay an exercise price in cash to receive one share of common stock at a time when they could elect the zero exercise price option to receive more shares of common stock than they would receive if they did pay an exercise price. If each holder of the Class H-1 Warrants elects the zero exercise price option, the number of shares of common stock could increase to up to 32,786,880 shares of common stock underlying each Class H-1 Warrant. As such, holders of the Class H-1 Warrants may elect to be issued up to 32,786,880 shares of common stock upon the exercise of the Class H